Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03937661 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders

Study acronym: PRP
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jan 30, 2025 to Jan 30, 2027
    • Study completion date: Aug 30, 2025 to Aug 30, 2028
    v11
  2. Re-verified, no change to tracked fieldsv10
  3. Primary completion date: Jan 30, 2024 to Jan 30, 2025
    • Study completion date: Jan 30, 2024 to Aug 30, 2025
    v9
  4. Primary and study completion dates: Jan 30, 2023 to Jan 30, 2024v8
  5. Primary and study completion dates: Jan 30, 2021 to Jan 30, 2023v7 Show 5 more changesShow less
    • Primary endpoints revised (2)
    • Eligibility criteria expanded, about 64 words
    • Secondary endpoints revised (2)
    • Study description expanded, about 19 words
    • Study title revised
Show 5 earlier versionsHide 5 earlier versions
  1. Eligibility criteria expanded, about 15 wordsv6
  2. Secondary endpoints: details revised at 1 of 2 entriesv5
  3. Primary completion date: Oct 30, 2020 to Jan 30, 2021
    • Site contact updated
    v4
  4. Study title revisedv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Autologous PRP intra ovarian infusion may improve ovarian response, patients' hormonal profile as well as fresh embryo transfer (ET)-ICSI cycles' outcome in patients presenting with Poor Ovarian Response (POR).
Trial Details
NCT Number NCT03937661
Lead Sponsor Genesis Athens Clinic
Collaborators: National and Kapodistrian University of Athens
Conditions
(from sponsor)		 Ovary; Anomaly, Infertility, Female
Related terms Congenital Abnormalities, Infertility, Female
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov